Cargando…
A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
Anti-LGI1 antibody encephalitis and anti-mGluR5 are both uncommon encephalitis, and we report the first case of autoimmune encephalitis (AE) with dual seropositive antibodies of leucine-rich glioma-inactivated 1 (LGI1) and mGluR5. PATIENT CONCERNS: We present a case of AE with dual seropositive anti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622628/ https://www.ncbi.nlm.nih.gov/pubmed/36316880 http://dx.doi.org/10.1097/MD.0000000000031063 |
_version_ | 1784821815073308672 |
---|---|
author | Huo, Tiantian Luo, Xintong Zhao, Jingru Wang, Tianjun Chen, Jinghong |
author_facet | Huo, Tiantian Luo, Xintong Zhao, Jingru Wang, Tianjun Chen, Jinghong |
author_sort | Huo, Tiantian |
collection | PubMed |
description | Anti-LGI1 antibody encephalitis and anti-mGluR5 are both uncommon encephalitis, and we report the first case of autoimmune encephalitis (AE) with dual seropositive antibodies of leucine-rich glioma-inactivated 1 (LGI1) and mGluR5. PATIENT CONCERNS: We present a case of AE with dual seropositive antibodies of LGI1 and mGluR5 in a 65-year-old woman who presented with sudden onset left faciobrachial dystonic seizures and unresponsive for 5 hours. DIAGNOSIS: The patient was diagnosed with anti-LGI1 AE and anti-mGluR5 AE mainly based on the clinical symptoms and further test of the antibody in serum and cerebral spinal fluid (CSF). INTERVENTIONS AND OUTCOMES: The patient was treated with glucocorticoid intravenous drip. We also gave her the therapy of immunoglobulin (25 g q.d) for 5 days and anti-epileptic therapy. She had no more convulsions on the left side of the face and limbs. She did not complain of any uncomfort until July 18. LESSONS: Early recognition of AE is crucial. Specific autoantibodies are associated with corresponding syndromes. Our patient was initially diagnosed with acute ischemic stroke. Therefore, we should conduct further study on the related symptoms of AE. |
format | Online Article Text |
id | pubmed-9622628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-96226282022-11-03 A Chinese female patient with LGI1 and mGluR5 antibodies: A case report Huo, Tiantian Luo, Xintong Zhao, Jingru Wang, Tianjun Chen, Jinghong Medicine (Baltimore) Research Article Anti-LGI1 antibody encephalitis and anti-mGluR5 are both uncommon encephalitis, and we report the first case of autoimmune encephalitis (AE) with dual seropositive antibodies of leucine-rich glioma-inactivated 1 (LGI1) and mGluR5. PATIENT CONCERNS: We present a case of AE with dual seropositive antibodies of LGI1 and mGluR5 in a 65-year-old woman who presented with sudden onset left faciobrachial dystonic seizures and unresponsive for 5 hours. DIAGNOSIS: The patient was diagnosed with anti-LGI1 AE and anti-mGluR5 AE mainly based on the clinical symptoms and further test of the antibody in serum and cerebral spinal fluid (CSF). INTERVENTIONS AND OUTCOMES: The patient was treated with glucocorticoid intravenous drip. We also gave her the therapy of immunoglobulin (25 g q.d) for 5 days and anti-epileptic therapy. She had no more convulsions on the left side of the face and limbs. She did not complain of any uncomfort until July 18. LESSONS: Early recognition of AE is crucial. Specific autoantibodies are associated with corresponding syndromes. Our patient was initially diagnosed with acute ischemic stroke. Therefore, we should conduct further study on the related symptoms of AE. Lippincott Williams & Wilkins 2022-10-28 /pmc/articles/PMC9622628/ /pubmed/36316880 http://dx.doi.org/10.1097/MD.0000000000031063 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Huo, Tiantian Luo, Xintong Zhao, Jingru Wang, Tianjun Chen, Jinghong A Chinese female patient with LGI1 and mGluR5 antibodies: A case report |
title | A Chinese female patient with LGI1 and mGluR5 antibodies: A case report |
title_full | A Chinese female patient with LGI1 and mGluR5 antibodies: A case report |
title_fullStr | A Chinese female patient with LGI1 and mGluR5 antibodies: A case report |
title_full_unstemmed | A Chinese female patient with LGI1 and mGluR5 antibodies: A case report |
title_short | A Chinese female patient with LGI1 and mGluR5 antibodies: A case report |
title_sort | chinese female patient with lgi1 and mglur5 antibodies: a case report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622628/ https://www.ncbi.nlm.nih.gov/pubmed/36316880 http://dx.doi.org/10.1097/MD.0000000000031063 |
work_keys_str_mv | AT huotiantian achinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT luoxintong achinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT zhaojingru achinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT wangtianjun achinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT chenjinghong achinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT huotiantian chinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT luoxintong chinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT zhaojingru chinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT wangtianjun chinesefemalepatientwithlgi1andmglur5antibodiesacasereport AT chenjinghong chinesefemalepatientwithlgi1andmglur5antibodiesacasereport |